Wednesday, January 07, 2009
 
 
  Home arrow Medical Students arrow Quotes to Note arrow MAP.Code of Conduct.Australia
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

The Morning After Pill:  "0.5 percent of women have a genetic susceptibility to thrombo-embolic disease (blood clots). When these women take the 'morning-after' pill - which is equal in strength to taking 50 regular birth control tablets - a blood clot might form."

--Dr. Ellen Grant, Lancet (2001)

 
MAP.Code of Conduct.Australia PDF Print E-mail

The Morning After Pill (MAP, EC): 

"...Researchers have said that it acts in at least 2 ways to end a pregnancy:   

"a.   By damaging the lining of the womb so that implantation of the human embryo - the unseen patient - cannot occur.    

"b. Research in mice has also indicated that if an embryo attaches to the womb, the body reabsorbs it, thereby ending the embryo’s life.    

"Because the MAP can act via these two methods, it must be classified as an abortifacient - a drug that can cause an abortion. The fact that the MAP reduces the expected pregnancy rate by 87% supports the claim that it frequently acts to end the life of a human embryo. Therefore, due to the danger to the health of the human embryo caused by the MAP, my Code of Professional Conduct, parts 1.1 and 1.2,  forbids me from selling this drug." [Policy - Code of Professional Conduct. Pharmaceutical Society of Australia. Endorsed by National Council 3/1998]



 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2009 All Rights Reserved